- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Environmental and Public Health
Volume 2012 (2012), Article ID 312836, 10 pages
A Water-Damaged Home and Health of Occupants: A Case Study
1Citrus Heights, CA, USA
2Progressive Healthcare Group, Benson, AZ 85602, USA
3Neurotest, Inc., Pasadena, CA 91107, USA
4USC Keck School of Medicine, Los Angeles, CA 90089, USA
5Center for ENT and Facial Plastic Surgery, Atlanta, GA 30327, USA
6Compliance Solution, Honolulu, HI 96823, USA
Received 16 July 2011; Accepted 4 September 2011
Academic Editor: Janette Hope
Copyright © 2012 Jack Dwayne Thrasher et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- W. J. Fisk, E. A. Eliseeva, and M. J. Mendel, “Association of residential dampness and mold with respiratory tract infections and bronchitis: a meta-analysis,” Environmental Health, vol. 9, no. 72, 2010.
- M. J. Mendell, A. G. Mirer, K. Cheung, M. Tong, and J. Douwes, “Respiratory and allergic health effects of dampness, mold, and dampness-related agents: a review of the epidemiologic evidence,” Environmental Health Perspectives, vol. 119, no. 6, pp. 748–756, 2011.
- D. Mudarri and W. J. Fisk, “Public health and economic impact of dampness and mold,” Indoor Air, vol. 17, no. 3, pp. 226–235, 2007.
- J. H. Park and J. M. Cox-Ganser, “Mold exposure and respiratory health in damp indoor environments,” Frontiers in Bioscience E, vol. 3, pp. 575–571, 2011.
- D. P. Dennis, “Chronic sinusitis: defective T-cells responding to superantigen treated by reduction of fungi in the nose and air,” Archives of Environmental Health, vol. 58, no. 7, pp. 433–441, 2004.
- D. Dennis, D. Robertson, L. Curtis, and J. Black, “Fungal exposure endocrinopathy in sinusitis with growth hormone deficiency: Dennis-Robertson syndrome,” Toxicology and Industrial Health, vol. 25, no. 9-10, pp. 669–680, 2009.
- L. Empting, “Neurologic and neuropsychiatric syndrome features of mold and mycotoxin exposure,” Toxicology and Industrial Health, vol. 25, no. 9-10, pp. 577–582, 2009.
- K. H. Kilburn, “Role of molds and mycotoxins in being sick in buildings: neurobehavioral and pulmonary impairment,” Advances in Applied Microbiology, vol. 55, pp. 339–359, 2004.
- K. H. Kilburn, “Neurobehavioral and pulmonary impairment in 105 adults with indoor exposure to molds compared to 100 exposed to chemicals,” Toxicology and Industrial Health, vol. 25, no. 9-10, pp. 681–692, 2009.
- K. H. Kilburn, J. D. Thrasher, and N. B. Immers, “Do terbutaline- and mold-associated impairments of the brain and lung relate to autism?” Toxicology and Industrial Health, vol. 25, no. 9-10, pp. 703–710, 2009.
- W. J. Rea, N. Didriksen, T. R. Simon, Y. Pan, E. J. Fenyves, and B. Griffiths, “Effects of toxic exposure to molds and mycotoxins in building-related illnesses,” Archives of Environmental Health, vol. 58, no. 7, pp. 399–405, 2004.
- W. J. Rea, Y. Pan, and B. Griffiths, “The treatment of patients with mycotoxin-induced disease,” Toxicology and Industrial Health, vol. 25, no. 9-10, pp. 711–714, 2009.
- E. Bloom, E. Nyman, A. Must, C. Pehrson, and L. Larsson, “Molds and mycotoxins in indoor environments–a survey in water-damaged buildings,” Journal of Occupational and Environmental Hygiene, vol. 6, no. 11, pp. 671–678, 2009.
- J. D. Thrasher and S. Crawley, “The biocontaminants and complexity of damp indoor spaces: more than what meets the eyes,” Toxicology and Industrial Health, vol. 25, no. 9-10, pp. 583–615, 2009.
- M. Täubel, M. Sulyok, V. Vishwanath et al., “Co-occurrence of toxic bacterial and fungal secondary metabolites in moisture-damaged indoor environments,” Indoor Air, vol. 21, no. 5, pp. 368–375, 2011.
- V. Polizzi, B. Delmulle, A. Adams et al., “JEM spotlight: fungi, mycotoxins and microbial volatile organic compounds in mouldy interiors from water-damaged buildings,” Journal of Environmental Monitoring, vol. 11, no. 10, pp. 1849–1858, 2009.
- WHO, Dampness and Mould: WHO Guidelines for Indoor Air Quality, Euro Non Serial Publications, 2009.
- A. Ciegler, R. F. Vesonder, and R. J. Cole, “Tremorgenic mycotoxins,” in Mycotoxins and Other Fungal Related Food Problems, J. V. Rodricks, Ed., Advances in Chemistry Series no. 149, pp. 163–177, American Chemical Society, 1976.
- N. Kyriakidis, E. S. Waight, J. B. Day, and P. G. Mantle, “Novel metabolites from Penicillium crustosum, including penitrem E, a tremorgenic mycotoxin,” Applied and Environmental Microbiology, vol. 42, no. 1, pp. 61–62, 1981.
- W. E. Braselton and P. C. Rumler, “MS/MS screen for the tremorgenic mycotoxins roquefortine and penitrem a,” Journal of Veterinary Diagnostic Investigation, vol. 85, no. 4, pp. 515–518, 1996.
- K. Khoufache, O. Puel, N. Loiseau et al., “Verruculogen associated with Aspergillus fumigatus hyphae and conidia modifies the electrophysiological properties of human nasal epithelial cells,” BMC Microbiology, vol. 7, article 11, 2007.
- I. Kosalec, M. Š. Klarić, and S. Pepeljnjak, “Verruculogen production in airborne and clinical isolates of Aspergillus fumigatus Fres,” Acta Pharmaceutica, vol. 55, no. 4, pp. 357–364, 2005.
- C. S. Coffey, R. E. Sonnenburg, C. T. Melroy, M. G. Dubin, and B. A. Senior, “Endoscopically guided aerobic cultures in postsurgical patients with chronic rhinosinusitis,” American Journal of Rhinology, vol. 20, no. 1, pp. 72–76, 2006.
- A. Chakrabarti, D. W. Denning, B. J. Ferguson et al., “Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies,” Laryngoscope, vol. 119, no. 9, pp. 1809–1818, 2009.
- K. Mantovani, A. A. Bisanha, R. C. Demarco, E. Tamashiro, R. Martinez, and W. T. Anselmo-Lima, “Maxillary sinuses microbiology from patients with chronic rhinosinusitis,” Brazilian Journal of Otorhinolaryngology, vol. 76, no. 5, pp. 548–551, 2010.
- J. Barkman, Home Inspection Report, Kihei, Hawaii, USA, 2009.
- Engineering Dynamics Corp, “Dizy Residence Report,” Maui, Hawaii, USA.
- Pugliese and Thrasher, “Multiple testing parameters of water damaged buildings,” The Canadian Journal of Environmental Education. In press.
- H. Feltman, G. Schubert, S. Khan, M. Jain, et al., “Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa,” Journal of Microbiology, vol. 147, pp. 2659–2669, 2001.
- D. E. Griffith, T. Aksamit, B. A. Brown-Elliott et al., “An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 4, pp. 367–416, 2007.
- M. Kapadia, K. V. I. Rolston, and X. Y. Han, “Invasive Streptomyces infections: six cases and literature review,” American Journal of Clinical Pathology, vol. 127, no. 4, pp. 619–624, 2007.
- S. Copeland, H. S. Warren, S. F. Lowery, et al., “Acute respiratory response to endotoxin in mice and humans,” Clinical and Diagnostic Laboratory Immunology, vol. 12, pp. 60–57, 2005.
- F. D. Martinez, “CD14, endotoxin, and asthma risk: actions and interactions,” Proceedings of the American Thoracic Society, vol. 4, no. 3, pp. 221–225, 2007.
- R. Rylander, “Endotoxin and occupational airway disease,” Current Opinion in Allergy and Clinical Immunology, vol. 6, no. 1, pp. 62–68, 2006.
- J. Thorn and R. Rylander, “Inflammatory response after inhalation of bacterial endotoxin assessed by the induced sputum technique,” Thorax, vol. 53, no. 12, pp. 1047–1052, 1998.
- M. A. Andersson, R. Mikkola, R. M. Kroppenstedt et al., “The mitochondrial toxin produced by Streptomyces griseus strains isolated from an indoor environment is valinomycin,” Applied and Environmental Microbiology, vol. 64, no. 12, pp. 46–67, 1998.
- Z. Islam, C. J. Amuzie, J. R. Harkema, and J. J. Pestka, “Neurotoxicity and inflammation in the nasal airways of mice exposed to the macrocyclic trichothecene mycotoxin roridin A: kinetics and potentiation by bacterial lipopolysaccharide coexposure,” Toxicological Sciences, vol. 98, no. 2, pp. 526–541, 2007.
- A. Roy-Burman, R. H. Savel, S. Racine et al., “Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections,” Journal of Infectious Diseases, vol. 183, no. 12, pp. 1767–1774, 2001.
- K. Huttunen, J. Pelkonen, K. F. Nielsen, U. Nuutinen, J. Jussila, and M. R. Hirvonen, “Synergistic interaction in simultaneous exposure to Streptomyces californicus and Stachybotrys chartarum,” Environmental Health Perspectives, vol. 112, no. 6, pp. 659–665, 2004.
- D. G. Hooper, V. E. Bolton, F. T. Guilford, and D. C. Straus, “Mycotoxin detection in human samples from patients exposed to environmental molds,” International Journal of Molecular Sciences, vol. 10, no. 4, pp. 1465–1475, 2009.
- T. L. Brasel, D. R. Douglas, S. C. Wilson, and D. C. Straus, “Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins on particulates smaller than conidia,” Applied and Environmental Microbiology, vol. 71, no. 1, pp. 114–122, 2005.
- T. L. Brasel, A. W. Campbell, R. E. Demers et al., “Detection of trichothecene mycotoxins in sera from individuals exposed to Stachybotrys chartarum in indoor environments,” Archives of Environmental Health, vol. 59, no. 6, pp. 317–323, 2004.
- D. C. Straus, “The possible role of fungal contamination in sick building syndrome,” Frontiers in Bioscience E, vol. 3, pp. 562–580, 2011.
- T. Reponen, S. C. Seo, F. Grimsley, T. Lee, C. Crawford, and S. A. Grinshpun, “Fungal fragments in moldy houses: a field study in homes in New Orleans and Southern Ohio,” Atmospheric Environment, vol. 41, no. 37, pp. 8140–8149, 2007.
- S. H. Cho, S. C. Seo, D. Schmechel, S. A. Grinshpun, and T. Reponen, “Aerodynamic characteristics and respiratory deposition of fungal fragments,” Atmospheric Environment, vol. 39, no. 30, pp. 5454–5465, 2005.
- R. L. Górny, “Filamentous microorganisms and their fragments in indoor air—a review,” Annals of Agricultural and Environmental Medicine, vol. 11, no. 2, pp. 185–197, 2004.
- J. H. Hope and B. E. Hope, “Ochratoxin-A from inhalation exposure associated with focal segmental glomerulosclerosis: two human cases,” The Canadian Journal of Environmental Education. In Press.
- D. Hibi, Y. Susuki, Y. Ishi, et al., “Site-specific in vivo mutagenicity in the kidney of bpt deta rats given a carcinogenic dose of Ochratoxin A.,” Toxicological Sciences, vol. 122, pp. 406–414, 2011.
- N. Palma, S. Cinelli, O. Sapora, S. H. Wilson, and E. Dogliotti, “Ochratoxin A-induced mutagenesis in mamalian cells is consistent with the production of oxidative stress,” Chemical Research in Toxicology, vol. 20, pp. 1031–1037, 2007.
- W. Karmus, P. Dimitrov, V. Simeonov, S. Tsolova, and V. Batuman, “Offspring of parents with Balkan Endemic Nephropathy have igher C-reactive protein levels suggestive of inflammatory processes: a longitudinal study,” BMC Nephrology, vol. 10, article 10, 2009.